CompletedNot Applicable

Early Adjuvant Diagnosis of Pulmonary Nodules Based on CTC.

China172 participantsStarted 2019-01-01

Plain-language summary

The goal of this observational clinical trial is to evaluate the value of circulating tumor cell detection in the early diagnosis of malignant pulmonary nodule. The main questions it aims to answer is: the sensitivity and specificity of peripheral blood circulating tumor cell detection in differentiating benign and malignant pulmonary nodules (≤3cm). Participants will be asked provide 4mL of peripheral blood for the test.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Peripheral blood: 1.5 x 10\^9/L≤ absolute neutrophil count (ANC) ≤15 x 10\^9/L, platelets ≥100 x 10\^9/L, hemoglobin ≥9.0 g/dL; Prothrombin time (PT) ≥11 seconds, International normalized ratio (INR) ≥0.8;
✓. Bilirubin ≤1.5 times the upper limit of normal, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤2.5 times the upper limit of normal;
✓. Serum creatinine ≤1.5 times the upper limit of normal value.

What they're measuring

sensitivity

Timeframe: until the samples are collected and tested as planned, up to 72 months

specificity

Timeframe: until the samples are collected and tested as planned, up to 72 months

Trial details

NCT IDNCT06187935

SponsorChina-Japan Friendship Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-31

View on ClinicalTrials.gov More Pulmonary Nodules, Solitary trials